Maternal MTR genotype contributes to the risk of non-syndromic cleft lip and palate in the Polish population

Clinical Genetics

Volumn 69, Issue 6, 2006, Pages 512-517

  Mostowska, Adrianna ^a   Hozyasz, K K ^b   Jagodzinski, P P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF MOTHER AND CHILD   (Poland)

Author keywords

CL P; Maternal genotype; MTHFD1; MTHFR; MTR; Polymorphisms; RFC1

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FORMATE TETRAHYDROFOLATE LIGASE; METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; METHIONINE SYNTHASE; REDUCED FOLATE CARRIER;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLEFT LIP PALATE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; MOTHER; POLAND; PREVALENCE; PRIORITY JOURNAL; PROGENY; RISK FACTOR; STATISTICAL SIGNIFICANCE;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADULT; CLEFT LIP; CLEFT PALATE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MOTHERS; POINT MUTATION; POLAND; RISK FACTORS;

EID: 33646765346     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2006.00618.x     Document Type: Article

References (37)

1. Schutte BC, Murray JC. The many faces and factors of orofacial clefts. Hum Mol Genet 1999: 8 (10): 1853-1859.
2. Murray JC. Gene/environment causes of cleft lip and/or palate. Clin Genet 2002: 61 (4): 248-256.
3. Stanier P, Moore GE. Genetics of cleft lip and palate: Syndromic genes contribute to the incidence of non-syndromic clefts. Hum Mol Genet 2004: 13 Spec No 1: R73-R81.
4. Cobourne MT. The complex genetics of cleft lip and palate. Eur J Orthod 2004: 26 (1): 7-16.
5. Jugessur A, Murray JC. Orofacial clefting: Recent insights into a complex trait. Curr Opin Genet Dev 2005: 15 (3): 270-278.
6. Mills JL, Kirke PN, Molloy AM et al. Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet 1999: 86 (1): 71-74.
7. Shotelersuk V, Ittiwut C, Siriwan P et al. Maternal 677ct/1298AC genotype of the MTHFR gene as a risk factor for cleft lip. J Med Genet 20E3: 40 (5): e64.
8. Shaw GM, Rozen R, Finnell RH et al. Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. Am J Med Genet 1998: 80 (3): 196-198.
9. Blanton SH, Kolle BS, Hecht JT et al. No evidence supporting MTHFR as a risk factor in the development of familial NSCLP. Am J Med Genet 2000: 92 (5): 370-371.
10. Blanton SH, Patel S, Hecht JT et al. MTHFR is not a risk factor in the development of isolated nonsyndromic cleft lip and palate. Am J Med Genet 2002: 110 (4): 404-405.
11. Vieira AR, Murray JC, Trembath D et al. Studies of reduced folate carrier 1 (RFC1) A80G and 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms with neural tube and orofacial cleft defects. Am J Med Genet A 2005: 135 (2): 220-223.
12. Martinelli M, Scapoli L, Pezzetti F et al. C677T variant form at the MTHFR gene and CL/P: A risk factor for mothers? Am J Med Genet 2001: 98 (4): 357-360.
13. Prescott NJ, Winter RM, Malcolm S. Maternal MTHFR genotype contributes to the risk of non-syndromic cleft lip and palate. J Med Genet 2002: 39 (5): 368-369.
14. Pezzetti F, Martinelli M, Scapoli L et al. Maternal MTHFR variant forms increase the risk in offspring of isolated nonsyndromic cleft lip with or without cleft palate. Hum Mutat 2004: 24 (1): 104 -105.
15. Bailey LB, Berry RJ. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 2005: 81 (5): 1213S-1217S.
16. Doolin MT, Barbaux S, McDonnell M et al. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 2002: 71 (5): 1222-1226.
17. Bosco P, Gueant-Rodriguez RM, Anello G et al. Methionine synthase (MTR) 2756 (A→G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A 2003: 121 (3): 219-224.
18. Brody LC, Conley M, Cox C et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/ methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 2002: 71 (5): 1207-1215.
19. Parle-McDermott A, Mills JL, Kirke PN et al. MTHFD1 R653Q polymorphism is a maternal genetic risk factor for severe abruptio placentae. Am J Med Genet A 2005: 132 (4): 365-368.
20. Chango A, Emery-Fillon N, de Courcy GP et al. A polymorphism (80G→A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 2000: 70 (4): 310-315.
21. Shaw GM, Zhu H, Lammer EJ et al. Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects. Am J Epidemiol 2003: 158 (8): 747-752.
22. Pei L, Zhu H, Ren A et al. Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population. Birth Defects Res A Clin Mol Teratol 2005: 73 (6): 430-433.
23. Chango A, Fillon-Emery N, Mircher C et al. No association between common polymorphisms in genes of folate and homocysteine metabolism and the risk of Down's syndrome among French mothers. Br J Nutr 2005: 94 (2): 166-169.
24. Fang JY, Xiao SD. Folic acid, polymorphism of methyl-group metabolism genes, and DNA methylation in relation to GI carcinogenesis. J Gastroenterol 2003: 38 (9): 821-829.
25. Gemmati D, Ongaro A, Scapoli GL et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004: 13 (5): 787-794.
26. Skibola CF, Forrest MS, Coppede F et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004: 104 (7): 2155-2162.
27. Paz MF, Avila S, Fraga MF et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 2002: 62 (15): 4519-4524.
28. Kang S, Kim JW, Kang GH et al. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 2005: 96 (1): 173-180.
29. Harmon DL, Shields DC, Woodside JV et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999: 17 (4): 298-309.
30. Tsai MY, Bignell M, Yang F et al. Polygenic influence on plasma homocysteine: Association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels. Atherosclerosis 2000: 149 (1): 131-137.
31. Chen J, Stampfer MJ, Ma J et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 2001: 154 (3): 667-672.
32. Silaste ML, Rantala M, Sampi M et al. Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. J Nutr 2001: 131 (10): 2643-2647.
33. Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001: 293 (5532): 1068-1070.
34. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004: 22 (22): 4632-4642.
35. Steele W, Allegrucci C, Singh R et al. Human embryonic stem cell methyl cycle enzyme expression: Modelling epigenetic programming in assisted reproduction? Reprod Biomed Online 2005: 10 (6): 755-766.
36. Fenech M. The role of folic acid and Vitamin B12 in genomic stability of human cells. Mutat Res 2001: 475 (1-2): 57-67.
37. Gaspar DA, Pavanello RC, Zatz M et al. Role of the C677T polymorphism at the MTHFR gene on risk to nonsyndromic cleft lip with/without cleft palate: Results from a case-control study in Brazil. Am J Med Genet 1999: 87 (2): 197-199.